<DOC>
	<DOC>NCT01044810</DOC>
	<brief_summary>The primary objective of this study is to compare the effectiveness of EFV-based regimens in HIV-1-infected patients who; (1) were previously allergic to NVP and stopped all ARV simultaneously; (2) were previously allergic to NVP and continued the other NRTIs for a period of time, i.e. "staggered interruption"; and (3) started EFV-based regimens as an initial regimen (as controlled group).</brief_summary>
	<brief_title>Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity</brief_title>
	<detailed_description />
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>age 1870 years old documented HIV infection started EFVbased regimens between January 2002 and December 2008 at Bamrasnaradura Infectious Diseases Institute previously received nonHAART regimens such as dual NRTIs regimen, AZT monotherapy with singledose NVP in pregnancy patients previously received protease inhibitorbased regimen diseases or conditions that significantly affected either kidney or liver functions such as decompensated liver cirrhosis, ESRD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>HIV</keyword>
	<keyword>efavirenz</keyword>
	<keyword>nevirapine</keyword>
	<keyword>allergy</keyword>
	<keyword>rash</keyword>
	<keyword>Cohort Studies, Historical</keyword>
	<keyword>Retrospective Study</keyword>
	<keyword>exanthem</keyword>
	<keyword>Antiretroviral Agents</keyword>
	<keyword>Highly Active Antiretroviral Therapy</keyword>
	<keyword>HAART</keyword>
	<keyword>treatment failure</keyword>
</DOC>